How many clinical-trial readouts are scheduled for August 2027?

pdufa.bio currently tracks 41 clinical-trial readouts with dates in August 2027, each linked to a primary source. The list updates as new filings appear and dates shift.

What is a clinical-trial readout date?

A readout date is the estimated time a trial reports topline results, based on its registered primary-completion date; these are estimates and shift.

Does pdufa.bio predict whether these will be approved?

No. We do not publish per-drug approval probabilities. We provide the verified facts, primary-source links, and historical base rates so you can judge for yourself.

pdufa.bio

Calendar Readouts Devices Decisions Approvals/yr Trial odds Learn Research Methodology

Home › Readouts › August 2027

August 2027 clinical-trial readouts

trial-readout estimates for August 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.

← July 2027 September 2027 →

41 readouts

SMMT · Aug 2027 (est.)

Ivonescimab — Advanced Head and Neck Squamous Cell Carcinoma

SUPN · Aug 2027 (est.)

SPN-817 — Focal Onset Seizures

TLX · Aug 2027 (est.)

177Lu-TLX591 — Clear Cell Renal Cell Carcinoma (ccRCC)

TNYA · Aug 2027 (est.)

TN-201 — Hypertrophic Cardiomyopathy

TVTX · Aug 2027 (est.)

Pegtibatinase — Homocystinuria

VRCA · Aug 2027 (est.)

Part 1: VP-315 3 Day Dosing/Week — Common Warts

ZLAB · Aug 2027 (est.)

ZL-1310 — Solid Tumors

ACAD · Aug 2027 (est.)

ACP-204 — Major Depressive Disorder (MDD)

ADCT · Aug 2027 (est.)

Loncastuximab Tesirine — Follicular Lymphoma

ARTV · Aug 2027 (est.)

AB-101 — Lupus Nephritis - WHO Class III

ASND · Aug 2027 (est.)

TransCon CNP — Advanced Solid Tumor

RARE · Aug 2027 (est.)

Triheptanoin — Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)

PVLA · Aug 2027 (est.)

QTORIN — Angiokeratomas

NVCR · Aug 2027 (est.)

Temozolomide — Adenocarcinoma of Lung

NBIX · Aug 2027 (est.)

NBI-1065845 — Schizophrenia

BBOT · Aug 2027 (est.)

BBO-11818 — Non-Small Cell Lung Cancer

BHVN · Aug 2027 (est.)

BHV-8000 — Parkinson Disease

CLLS · Aug 2027 (est.)

UCART22 — B-cell Non-Hodgkin Lymphoma (B-NHL)

CLYM · Aug 2027 (est.)

Budoprutug — Immune Thrombocytopenia (ITP)

CRNX · Aug 2027 (est.)

Atumelnant — Carcinoid Syndrome

DFTX · Aug 2027 (est.)

DT120 — Autism Spectrum Disorder

IONS · Aug 2027 (est.)

ION582 — Angelman Syndrome

JNJ · Aug 2027 (est.)

Talquetamab — Multiple Myeloma

KPRX · Aug 2027 (est.)

KIO-301 — Retinitis Pigmentosa

SMMT · Aug 2027 (est.)

Ivonescimab — Biliary Tract Cancer

LCTX · Aug 2027 (est.)

AST-OPC1 — Spinal Cord Injury Cervical

VIR · Aug 2027 (est.)

VIR-5818 — Locally Advanced or Metastatic HER2-Expressing Cancers

VSTM · Aug 2027 (est.)

avutometinib — Thyroid Cancer

ARWR · Aug 2027 (est.)

Plozasiran — Homozygous Familial Hypercholesterolemia

PMVP · Aug 2027 (est.)

rezatapopt — Myelodysplastic Syndrome

NVCR · Aug 2027 (est.)

Temozolomide — Pancreatic Adenocarcinoma

CSLLY · Aug 2027 (est.)

CSL300 — End Stage Kidney Disease (ESKD)

ONCY · Aug 2027 (est.)

REOLYSIN — Ras-mutated Metastatic Colorectal Cancer

RADX · Aug 2027 (est.)

RAD101 — Imaging

ALNY · Aug 2027 (est.)

ALN-4324 — Obese or Overweight Healthy Volunteers

TLX · Aug 2027 (est.)

177Lu-TLX591 — ccRCC

RIGL · Aug 2027 (est.)

Fostamatinib Disodium — Myelodysplastic Syndromes

MIRM · Aug 2027 (est.)

Brelovitug — Chronic Hepatitis D

CRDF · Aug 2027 (est.)

Onvansertib — Small-cell Lung Cancer

BNTX · Aug 2027 (est.)

ONC-392 — Non Small Cell Lung Cancer

CANF · Aug 2027 (est.)

Piclidenoson — Lowe Syndrome

Looking for an approval probability for these? We deliberately don't publish one — here's why, and what we show instead (verified history + base rates).